
Breakthrough Vaccine for Deadly Nipah Virus Enters Human Clinical Trials
Researchers at the University of Tokyo have developed a promising vaccine candidate for Nipah virus, a highly lethal pathogen with fatality rates reaching 75 percent. The experimental vaccine will begin Phase 1 human safety trials in Belgium this April, offering hope for regions vulnerable to this devastating tropical disease.
